Zhang Mu-cheng, Wang Zheng-guang, Cheng Jin-xia, Wang Jian-lei, Zheng Shao-peng
Intensive Care Unit, People's Hospital of Huangshan Affiliated to Wannan Medical College, Huangshan 245000, Anhui, China.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 May;22(5):275-8.
To explore the value of the chronic obstructive pulmonary disease (COPD) and asthma physiology score (CAPS) in evaluating the severity and prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) complicated by type II respiratory failure.
Eighty-two cases with AECOPD complicated by type II respiratory failure between January 2005 and March 2009 were retrospectively analyzed. The severity in survivors and non-survivors was evaluated by CAPS and acute physiology and chronic health evaluation system (APACHE II score, APACHE III score), and retrospective and statistical analyses of all data were performed.
CAPS, APACHE II score, APACHE III score, duration of invasive positive pressure ventilation (IPPV) and days in intensive care unit of 19 cases in the death group were 34.21+/-9.89, 22.53+/-7.49, 75.11+/-18.07, (25.06+/-24.64) days, (32.42+/-25.49) days , respectively, while 63 cases of the survival group were 27.41+/-8.15, 18.65+/-5.34, 64.11+/-15.92, (5.23+/-5.50) days, (12.51+/-20.70) days, respectively, and there were significant differences between two groups (P<0.05 or P<0.01). The areas under receiver operating characteristic (ROC) curves of CAPS, APACHE II score and APACHE III score were 0.712 (P=0.005), 0.654 (P=0.043) and 0.655 (P=0.042), respectively. When CAPS score was 30.5, Youden index was the highest (0.435). The mortality rate had a positive correlation with CAPS. When the CAPS score was over 30, there was a tendency of increase in mortality rate.
CAPS is very useful to evaluate the severity and prognosis of patients with AECOPD complicated by type II respiratory failure. It is easy to perform, and better than APACHE II and APACHE III.
探讨慢性阻塞性肺疾病与哮喘生理学评分(CAPS)在评估慢性阻塞性肺疾病急性加重期(AECOPD)合并Ⅱ型呼吸衰竭患者严重程度及预后中的价值。
回顾性分析2005年1月至2009年3月期间82例AECOPD合并Ⅱ型呼吸衰竭患者的资料。采用CAPS、急性生理学与慢性健康状况评价系统(APACHEⅡ评分、APACHEⅢ评分)评估存活患者与死亡患者的严重程度,并对所有数据进行回顾性统计分析。
死亡组19例患者的CAPS、APACHEⅡ评分、APACHEⅢ评分、有创正压通气(IPPV)时间及重症监护病房住院天数分别为34.21±9.89、22.53±7.49、75.11±18.07、(25.06±24.64)天、(32.42±25.49)天,存活组63例患者分别为27.41±8.15、18.65±5.34、64.11±15.92、(5.23±5.50)天、(12.51±20.70)天,两组比较差异有统计学意义(P<0.05或P<0.01)。CAPS、APACHEⅡ评分及APACHEⅢ评分的受试者工作特征(ROC)曲线下面积分别为0.712(P=0.005)、0.654(P=0.043)、0.655(P=0.042)。当CAPS评分为30.5时,约登指数最高(0.435)。死亡率与CAPS呈正相关。当CAPS评分>30分时,死亡率有上升趋势。
CAPS对评估AECOPD合并Ⅱ型呼吸衰竭患者的严重程度及预后有重要价值,操作简便,优于APACHEⅡ和APACHEⅢ评分。